The Man Who Challenged Reality. For 32 years, Garo Armen has pursued a vision many believed was impossible.
FDA Approves Gedatolisib - Based Therapy for HR+/HER2− Advanced Breast Cancer Without PIK3CA Mutation
The Oncology Community Discusses the Recent FDA Approval of REVTORPYK
Farina Arreguin: AYA Roundtable for Young Cancer Patients
Akeso and MSKCC collaborate around a new Treatment for Gastric and GEJ adenocarcinoma - Akeso Biopharma
NK-Cell Immunotherapy: The Next Frontier in Cancer Treatment
KRAS Grows Up: The Breakthroughs and the Reckonings
Megan Sanders: One Year of Progress in Australia’s Lung Cancer Screening Program
